Next Article in Journal
Network Analysis of Biomarkers Associated with Occupational Exposure to Benzene and Malathion
Next Article in Special Issue
FA Sliding as the Mechanism for the ANT1-Mediated Fatty Acid Anion Transport in Lipid Bilayers
Previous Article in Journal
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances
Previous Article in Special Issue
Role of UCP2 in the Energy Metabolism of the Cancer Cell Line A549
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 11
10.3390/ijms24119414
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation

by
Ami Kobayashi
1,2,
Toshihiko Takeiwa
2,
Kazuhiro Ikeda
3 and
Satoshi Inoue
2,3,*
1
Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, 60 Fenwood Rd., Boston, MA 02115, USA
2
Department of Systems Aging Science and Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Itabashi-ku, Tokyo 173-0015, Japan
3
Division of Systems Medicine & Gene Therapy, Saitama Medical University, Hidaka 350-1241, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(11), 9414; https://doi.org/10.3390/ijms24119414
Submission received: 1 May 2023 / Revised: 23 May 2023 / Accepted: 25 May 2023 / Published: 28 May 2023
(This article belongs to the Special Issue Transport Mechanisms of Mitochondrial Membrane Proteins)
Browse Figures
Review Reports Versions Notes

Abstract

:
The mitochondrial electron transport chain (ETC) plays an essential role in energy production by inducing oxidative phosphorylation (OXPHOS) to drive numerous biochemical processes in eukaryotic cells. Disorders of ETC and OXPHOS systems are associated with mitochondria- and metabolism-related diseases, including cancers; thus, a comprehensive understanding of the regulatory mechanisms of ETC and OXPHOS systems is required. Recent studies have indicated that noncoding RNAs (ncRNAs) play key roles in mitochondrial functions; in particular, some ncRNAs have been shown to modulate ETC and OXPHOS systems. In this review, we introduce the emerging roles of ncRNAs, including microRNAs (miRNAs), transfer-RNA-derived fragments (tRFs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs), in the mitochondrial ETC and OXPHOS regulation.

1. Introduction

Mitochondria play a crucial role in a diverse range of biological processes in eukaryotic cells. One of the important functions of mitochondria is to generate energy in the cell via electron transport and oxidative phosphorylation (OXPHOS). The mitochondrial electron transport chain (ETC) consists of a series of electron carriers embedded in the inner mitochondrial membrane. Electrons from NADH and FADH2, which are produced in the metabolic pathways of glucose and other nutrients, are transferred along the ETC, leading to the transport of protons across the membrane from the mitochondrial matrix to the intermembrane space. This establishes a proton gradient across the inner mitochondrial membrane, which is then used by the ATP synthase enzyme to produce ATP via OXPHOS. OXPHOS is the process of phosphorylating ADP to form ATP using energy from the proton gradient established by the ETC. The ETC comprises a series of four enzymatic complexes that contain complex I (NADH ubiquinone oxidoreductase/NADH dehydrogenase), complex II (succinate ubiquinone oxidoreductase/succinate dehydrogenase), complex III (ubiquinol cytochrome c oxidoreductase/cytochrome bc1 complex), and complex IV (cytochrome c oxidase). OXPHOS is accomplished by complex V (ATP synthase) [1]. Some of these complexes generate higher-order assemblies called ‘supercomplexes’ [1,2] (Figure 1). In mammalian cells, a supercomplex called ‘respirasome’ is the major structure, which is composed of one complex I, two complex IIIs, and one complex IV (I + III2 + IV). Although the biological function and regulation of the mitochondrial supercomplex assembly is highly debated, it can contribute to efficient energy production [3,4,5,6], reducing reactive oxygen species (ROS) [7,8,9], and the stability of complex I [10]. The ETC complexes and complex V are composed of specific protein subunits that are encoded in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) [11]. Some mutations of these subunits as well as assembly factors of ETC complexes and complex V are known to cause the dysregulation of mitochondrial functions associated with mitochondrial diseases such as mitochondrial encephalopathy, resulting in lactic acidosis and stroke-like episodes (MELAS), and Leigh syndrome. Furthermore, ETC/OXPHOS disorders are assumed to result in metabolism-related diseases and cancers [12,13,14,15,16]. Thus, a comprehensive understanding of ETC/OXPHOS regulation is crucial for precise diagnosis of and therapeutic intervention in mitochondria- and metabolism-related diseases and cancers.
Recent studies, including next-generation sequencing strategies, have reported that noncoding RNAs (ncRNAs) play key roles in mitochondrial functions, such as the ETC and OXPHOS, through various biological processes, including epigenetic and post-transcriptional gene regulation, and are involved in mitochondria- and metabolism-related diseases. For example, among microRNAs (miRNAs), a type of noncoding RNA, miR-181c, has been reported to be associated with reduced exercise capacity and cardiac dysfunction via inhibiting the translation of cytochrome c oxidase subunit 1 (COX1) and reducing complex IV’s function [17]. In another type of ncRNA, namely, long ncRNAs (lncRNAs), metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) has been suggested to promote hepatocellular carcinoma (HCC) cell proliferation, migration, and invasion by epigenetically regulating mtDNA-encoded ETC-related genes [18]. These ncRNAs may be promising targets in the diagnosis and treatment of related diseases [19,20].
In this review, we summarize the functional roles of ncRNAs, including miRNAs, transfer RNA-derived fragments (tRFs), lncRNAs, and circular RNAs (circRNAs), in the cross-talk signaling between mitochondria and the nucleus targeting regulated ETC complexes in mammalian cells.

2. Species and Classification of ncRNAs Affecting Mitochondria–Nucleus Crosstalk

In mammalian cells, numerous ncRNAs are synthesized to exhibit their various functions, including RNA splicing, RNA modification, and mRNA translation. ncRNAs are classified according to their length and structures. Small ncRNAs (sncRNAs) are classified as ncRNAs that are shorter than 200 nucleotides. miRNAs are a class of sncRNAs that are approximately 22 nucleotides long. miRNAs are synthesized as primary transcripts in the nucleus and are subsequently cleaved by the DROSHA/DiGeorge syndrome critical region 8 (DGCR8) complex to form single stem-loop precursor molecules, which are known as pre-miRNAs. Pre-miRNAs are generally transported to the cytoplasm by a nuclear transport receptor, Exportin 5, along with a cofactor RanGTP, and are then further cleaved by DICER1 to generate mature double-stranded miRNA duplexes [21]. In most cases, the miRNA duplex is incorporated into the RNA-binding protein argonaute 2 (AGO2) in mammalian cells; then, only one RNA strand (the guide strand) forms a complex with AGO2, leading to the formation of the miRNA-induced silencing complex (miRISC). The miRISC typically recognizes the 3′ untranslated region (3′ UTR) of target mRNAs using the guide strand and downregulates the translation and stability of these mRNAs. [22,23,24,25]. Besides their role in negative post-transcriptional regulation, miRNAs have been proposed to possess non-canonical functions outside the cytoplasm. For example, some miRNAs may act as chromatin and transcriptional regulators in the nucleus and as translational activators in mitochondria [26,27]. Mitochondrially located miRNAs are commonly termed “mitomiRs”, which are derived from either transcripts of mitochondria or the nuclear genome [28,29]. Nuclear genome-encoded mitomiRs are more abundant in mitochondria compared to mitochondrial genome-encoded genes. The nuclear genome-encoded mitomiRs are often located in loci within or close to mitochondrial genes so that their transcriptions can be coregulated.
tRNA derived fragments (tRFs) are another class of sncRNAs, which are approximately 16–35 nt in length and originate from the cleavage of precursor or mature tRNAs by specific nucleases under certain conditions including cellular stress [30,31,32,33,34,35,36,37]. tRFs can be derived from tRNAs found in both the nucleus and mitochondria [38,39,40,41,42,43]. In the human genome, more than 400 nuclear genes encode for approximately 280 different tRNA isotypes, and mitochondrial DNA encodes 22 tRNAs [44,45,46]. The diversity of tRNA molecules can be attributed to the presence of isoacceptors, which are tRNAs that carry the same amino acid but have different nucleotide sequences in both the body and the anticodon region, as well as isodecoders, which are tRNAs that possess the same anticodon and carry the same amino acid but differ in their nucleotide sequences in the body. Isoacceptors and isodecoders exist in several copies in the genome and their expressions are tissue- and cell-type-specific, which can be modulated by stress conditions. Post-transcriptional tRNA modifications can take place in the nucleus, cytosol, and mitochondria and are induced by various tRNA-modifying enzymes through modulating base pairing, tRNA folding, and stability [47]. On average, cytoplasmic and mitochondrial tRNAs in mammals contain 13 and 5 modified bases, respectively. Hypomodified tRNAs are targeted for degradation and undergo endonuclease-mediated fragmentation. tRFs resulting from the fragmentation of mature tRNAs are classified in six major structural categories based on their positions in the parental tRNA sequence, as follows: 5′-tRFs and 3′-tRFs generated from either distal end of mature tRNAs, internal tRFs (i-tRFs) from internal sequences of mature tRNAs, 5′-tRNA halves and 3′-tRNA halves from the cleavage of anticodon sites of mature tRNAs (tRNA-derived stress-induced RNA (tiRNA)-5s and -3s, respectively), and tRF-1s generated from precursor tRNAs. While angiogenin is the enzyme primarily responsible for cleaving the anticodon site, different endonucleases such as DICER, SLNF13, RNase T2, and RNase Z have been reported to generate other classes of tRFs [48,49,50]. tRF is often stimulated under stress conditions, in which post-transcriptional modifications of tRNA are impaired and function to repress gene expression in a manner similar to that of miRNAs [51,52]. Moreover, tRFs function as important modulators of many aspects of biological processes, including translation, apoptosis, immunity, nutritional uptake, and oxidative stress. Notably, with the innovative development of high-throughput sequencing techniques and bioinformatic analysis programs, it has become evident that nuclear genome-encoded tRNAs and mitochondrial tRNAs (mt-tRNAs) can produce tRFs [43,53,54,55]. mt-tRNA-derived tRFs (mt-tRFs) actively participate in intracellular communication and mitochondrial pathophysiology [55,56,57].
Noncoding RNAs longer than 200 nucleotides are referred to as lncRNAs. LncRNAs are transcribed from both nuclear and mitochondrial genomes, and there are approximately 20,000 lncRNA genes in humans, showing a diversity comparable to that of protein-coding genes. Although most lncRNAs remain functionally unannotated, some lncRNAs are thought to play essential roles in cell physiology and numerous biological processes and diseases, including various types of cancers [20,58,59,60,61]. Some nuclear genome-encoded lncRNAs have been found in mitochondria. For example, one nuclear genome-encoded lncRNA, namely, RNA component of mitochondrial RNA processing endoribonuclease (RMRP), is imported to the mitochondrial matrix [62]. This lncRNA was identified as a component of the mitochondrial RNA-processing endoribonuclease (MRP) and has been suggested to be involved in the generation of primers for mitochondrial DNA replication [63]. Meanwhile, the role of RMRP in mitochondria is debated, as recent studies have suggested that RNA primer generation is mediated by the premature arrest of RNA polymerase mitochondrial (POLRMT), and the 3′ half of this lncRNA (~130 nt) has been predominantly detected inside mitochondria [64,65].
CircRNAs are defined by their structure and not by their length. Such structures are single-stranded and covalently closed at the 5′ and 3′ ends [66,67]. The production of circRNA generally occurs through a distinct form of alternative splicing referred to as back-splicing. This process involves the 3′ end of an exon joining to the 5′ end of its own or a preceding exon through a 3′,5′-phosphodiester bond, resulting in a circular structure with a back-splicing junction site [68,69,70]. The unique structure of circRNAs provides them with a longer-half life and greater resistance to exonucleases than linear RNAs [68,69,71,72,73]. An increasing number of investigations uncovered diverse roles of circRNAs, such as acting as protein scaffolds or miRNA sponges, as well as having the ability to undergo translation into polypeptides [69,74,75]. Recently, mitochondria-located circRNAs have been discovered, and their functions have been investigated, which has expanded our understanding of circRNA derivation and mitochondrial transcriptome [76,77,78].
Regarding the targeting and import of nDNA-encoded ncRNAs into mammalian mitochondria, some proteins have been indicated as being involved in these processes. For example, polynucleotide phosphorylase (PNPASE) has been suggested to modulate the import of some ncRNAs, including RNase P RNA and RMRP. However, the mechanisms whereby nDNA-encoded ncRNAs target and are imported into mitochondria remain controversial, and thus new techniques are needed to precisely analyze nuclear-mitochondrial RNA dynamics (reviewed in [64]).
In this review, we define mitochondrial ncRNAs (mt-ncRNAs) as ncRNAs that are either transcribed from mtDNA regardless of subsequent mitochondrial localization or are mitochondria-located ncRNAs transcribed from nDNA. Another classification for ncRNAs that are neither located in mitochondria nor encoded by the mitochondrial genome but regulate mitochondrial functions is “mitochondria-associated ncRNAs”. Mitochondria-associated ncRNAs, a large portion of which are miRNAs, regulate mitochondrial functions by targeting nuclear genome-encoded mitochondrial mRNAs in the cytoplasm (Table 1, Figure 2). It has been suggested that mt-ncRNAs and mitochondria-associated noncoding RNAs regulate mitochondria–nucleus crosstalk through anterograde and retrograde signals [79,80].

3. Roles of microRNAs in the Regulation of Mitochondrial ETC Complexes and OXPHOS

Numerous mitomiRs have been shown to affect the levels of enzymes encoded by the mitochondrial genome in ETC complexes (Table 2 and Figure 3). For instance, the mitochondria-located miRNA let-7a in MCF-7 breast cancer cells decreases the activity of ETC complex I by inducing the destabilization of the mRNA encoding NADH ubiquinone oxidoreductase core subunit 4 (ND4), which is a subunit of complex I [81].
It has been suggested that miR-762 translocates into mitochondria in murine cardiomyocytes upon anoxia/reoxygenation treatment and decreases complex I activity and intracellular ATP levels, increases ROS levels, and enhances apoptotic cell death through suppressing the expression of NADH ubiquinone oxidoreductase chain 2 (ND2), which is a subunit of complex I [82]. Intriguingly, the administration of an inhibitor (antagomir) of miR-762 ameliorated myocardial ischemia/reperfusion injury in mice. Another example of the negative regulation of ETC complexes is provided by miR-181c, which binds to the 3′ UTR of cytochrome c oxidase subunit 1 (COX1) mRNA, encoding a subunit of complex IV and suppressing COX1 translation in rat cardiac myocytes. The overexpression of miR-181c dramatically decreased COX1 protein levels, leading to complex IV remodeling and altering mitochondrial function, including by precipitating augmented ROS production [17]. Notably, the systemic administration of miR-181c in rats diminished exercise capacity and caused heart failure [101]. For patients with heart failure with a preserved ejection fraction (HFpEF), exercise training is a treatment that commonly used to improve such patients’ aerobic capacity and quality of life. A recent study has shown that the circulating level of miR-181c is significantly higher in low responders to exercise training, suggesting that miR-181c may affect the exercise adaptation process in HFpEF patients partly through ETC regulation [102].
MitomiRs also negatively regulate ATP production by targeting complex V subunits. In a mouse model of type I diabetes mellitus, it has been shown that miR-378a redistributes to interfibrillar mitochondria (IFM) and downregulates the expression of ATP synthase F0 subunit 6 (ATP6), which encodes a subunit of complex V. The administration of an inhibitor of miR-378a alleviated ATP6 expression in IFM and heart failure in this mouse model [83]. In addition, miR-378a levels increased in subsarcolemmal mitochondria (SSM) but not in IFM, and miR-378a was responsible for modulating ATP6 expression in a mouse model of type II diabetes mellitus (db/db mice) [84]. Intriguingly, the knockout (KO) of miR-378a rescued complex V activity and cardiac function in db/db mice, thus suggesting that miR-378a may be a potential therapeutic target for treating diabetes mellitus. Further study on the molecular mechanism by which miR-378a targets mitochondria will be important for its clinical application [97].
For the positive regulation of ETC complexes, miR-21, a mitomiR, interacts with the open reading frame of the mRNA of cytochrome b (CYTB), encoding a subunit of complex III, and promotes the translation of CYTB to reduce ROS production. Experiments using spontaneous hypertensive rats have suggested that this mitomiR reduces blood pressure and suppresses cardiac hypertrophy [85]. MiR-1 is another example of a mitomiR that enhances the mitochondrial translation of ETC complexes. The muscle-specific miR-1, which is induced during myogenesis, directly and specifically recruits mRNAs encoding NADH ubiquinone oxidoreductase core subunit 1 (ND1), a subunit of complex I, and COX1 to mitochondrial ribosomes and promotes the translation of these mRNAs. This function of miR-1 is dependent on AGO2 but is independent of an AGO2 partner glycine-tryptophan protein of 182 kDa (GW182) [86]. Another mitomiR, miR-5787, promotes the translation of cytochrome c oxidase subunit 3 (COX3) in tongue squamous cell carcinoma (TSCC) cells. In Cal27 and Scc25 TSCC cells, the decrease in miR-5787 expression contributes to the shifting of glucose metabolism from OXPHOS to glycolysis and enhances cisplatin resistance [87].
It has also been demonstrated that several mitomiRs affect ETC complexes via regulating mitochondrial gene expression through a route that does not occur post-transcription. The mitomiR miR-2392 has been reported to directly regulate mtDNA transcription. miR-2392 recognizes target sequences in the H-strand and partially represses polycistronic mtDNA transcription in a cell-type-specific fashion. As a consequence, miR-2392 represses the expression of ETC complex subunits, such as ND4, COX1, and cytochrome c oxidase subunit 2 (COX2), to enhance anaerobic respiration in TSCC cells [88].
Mitochondria-associated miRNAs that are located in the cytoplasm modulate mitochondrial functions by targeting nuclear genome-encoded mitochondrial transcripts in the cytoplasm (Table 2 and Figure 3). Some studies have reported that miRNAs affect ATP synthesis by altering the expression of the ETC complex and complex V subunits. For instance, one brain-specific miRNA, miR-338, lowers the expression of the nuclear genome-encoded cytochrome c oxidase subunit 4 (COX4), a subunit of complex IV, after its binding to the 3′-UTR of its mRNA [89]. When an miR-338 inhibitor was transfected into axons of neural cells, metabolic oxygen consumption was increased by about 50% when compared with nontargeting cells. Other examples include miR-210, which modulates mitochondrial functions during hypoxia by directly reducing the expression levels of cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10, which facilitates the assembly of complex IV, and miR-101, which inhibits the replication of herpes simplex virus-1 (HSV-1) by downregulating the expression of ATP synthase F1 subunit β (ATP5B), a subunit of complex V [90,91]. miR-663 has been shown to increase the expression levels of ETC complex (I, II, III, and IV) subunits and assembly factors, thereby stabilizing the ETC supercomplexes. Authors have proposed that miR-663 may exert tumor-suppressive effects in breast cancer through enhancing ETC and OXPHOS activity [92]. Although ubiquinol cytochrome c reductase complex assembly factor 2 (UQCC2) is a potential target of miR-663, the mechanism by which miR-663 controls the expression of a wide range of ETC-related proteins remains unclear.
Interestingly, recent studies show the involvement of miRNAs in maladaptive retrograde signaling in response to OXPHOS dysfunction caused by pathogenic mtDNA mutations [103,104,105]. Dysfunction in OXPHOS caused by various pathological mutations modulates the levels of ROS-sensitive miRNAs. These miRNAs regulate the expression of mitochondrial tRNA-modifying enzymes [103,104]. By regulating the modification of mt-tRNAs, these miRNAs can potentially affect the speed and accuracy of mitochondrial translation, which can help mitigate the stoichiometric imbalance between mtDNA- and nuclear genome-encoded ETC complexes and complex V subunits originated through pathological mtDNA mutation. In addition, pathological mtDNA mutation can lead to the dysregulation of other miRNAs, which significantly affects the nuclear expression and potentially explains certain characteristics of mtDNA disease [106].

4. Roles of tRNA-Derived Small Fragments in the Regulation of Mitochondrial ETC Complexes

Since many mitochondrial diseases are caused by mutations in mt-tRNA genes, it follows that mitochondrial translation is involved in the pathophysiology of cells and tissues. Human mtDNA is a circular and double-stranded DNA consisting of 16,569 base pairs that encodes 37 genes. Thirteen of these genes are translated through specific decoding via mitochondrial ribosomes to the essential subunits of mitochondrial ETC complexes I, III, IV, and also complex V [107]. Mutations in mitochondrial DNA, particularly in mt-tRNA, are associated with syndromes such as myoclonic red fiber epilepsy (MERRF) and cardiomyopathy [108].
As tRNA-derived small fragments (tRFs) have recently been discovered to be regulators of mitochondrial biology, there are only a few reports on the roles of tRFs in relation to ETC complex regulation (Table 2 and Figure 3). As previously mentioned, mtDNA mutations causing OXPHOS dysfunction lead to changes in the levels of certain miRNAs controlling the modification of mt-tRNAs. One well-known example is the m.3243A>G mutation in the mitochondrially encoded tRNA leucine 1 (UUA/G) (MT-TL1) gene that encodes mt-tRNALeu(UUR). It is one of the most common mitochondrial pathogenic mutations, with a carrier frequency estimated in the range between 0.95 and 18.4 per 100,000 people in northern European populations [109,110,111]. This mutation is associated with several diseases such as MELAS, chronic progressive external ophthalmoplegia (CPEO), diabetes mellitus, and deafness. Although the manifestation of diseases varies significantly in different tissues based on the proportion of mutant mtDNA molecules present, patients with an m.3243A>G mutation in the MT-TL1 gene often show a severe, pre-existing deficiency in ETC complexes I and IV [112,113]. Accumulated data suggest that a deficiency in the aminoacylation of mutant mt-tRNALeu(UUR) and a lack of taurine-containing modifications of its anticodon wobble position affecting the recognition of UUG codons (U34) may constitute the origin of a mitochondrial translation defect [114,115,116,117,118]. This leads to a decrease in steady-state levels of ETC complexes and an affected mitochondrial respiration rate. In addition, ROS-sensitive miRNAs, termed miR-9/9*, are induced by ETC complex deficiency, which downregulates the expression of U34-modification enzymes and leads to the hypomodification of several mt-tRNA species, including mt-tRNAGlu(UUC). This causes the accumulation of mt-i-tRFGlu(UUC), which is produced by the action of the nuclease DICER. An increase in mt-i-tRFGlu(UUC) downregulates the expression of the nuclear gene mitochondrial pyruvate carrier 1 (MPC1), promoting the increase in extracellular lactate levels and leading to lactic acidosis, which is one of the well-known phenotypes of MELAS [57]. This report was the first to demonstrate the involvement of tRF in the phenotype of ETC complex deficiency by clarifying the mitochondria–nucleus crosstalk controlled by small noncoding RNAs, while the hypomodification at important sites in mature tRNAs is assumed to be the underlying mechanism of the clinical manifestation of this disease with ETC complex deficiencies [119,120,121,122]. Furthermore, a recent study reported that 5′-tRNA halves derived from tRNAHis(GTG), tRNAGlu(CTC), and tRNAGlu(TTC) (tiRNA-5His(GTG), tiRNA-5Glu(CTC), and tiRNA-5Glu(TTC), respectively) modulate MPC1 expression in neonatal rat pancreatic β cells and that an inhibitor cocktail of these tRNA halves suppresses the mitochondrial respiration, proliferation, and insulin secretion of these cells, suggesting their importance in postnatal β cell maturation. tiRNA-5His(GTG) and tiRNA-5Glu(CTC) are assumed to mediate these functions through mitochondria since they were found in a mitochondrial fraction [93].

5. Roles of Long Noncoding RNAs in the Regulation of Mitochondrial ETC Complexes

mt-lncRNAs, including both RNAs derived from mtDNA and nuclear genome-encoded lncRNAs transported into mitochondria, collaborate with transcription factors and other epigenetic regulators to regulate mitochondrial gene expression and function. These mt-lncRNAs play a crucial role in multiple gene-regulatory networks, serving as possible epigenetic mediators that coordinate nuclear and mitochondrial functions [62,123] (Table 2 and Figure 3). One mt-lncRNA that is reported to regulate the expression of ETC complexes is metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). MALAT1 is a nuclear genome-encoded lncRNA. A recent study indicated that MALAT1 is located in mitochondria in HepG2 hepatocellular carcinoma (HCC) cells. RNA reverse transcription-associated trap sequencing (RAT-seq) and chromatin isolation via an RNA purification (ChIRP) assay showed that MALAT1 interacts with multiple sites on mtDNA, including the D-loop region and the COX2 and NADH ubiquinone oxidoreductase core subunit 3 (ND3) gene loci. MALAT1 modulates the CpG methylation of mtDNA and the expression of mtDNA-encoded ETC-related genes, such as COX1, COX2, ND1, and ND3 genes. MALAT1 depletion impairs mitochondrial biogenesis and intracellular ATP synthesis; suppresses HCC cell proliferation, migration, and invasion; and induces mitochondria-associated apoptosis. Thus, MALAT1 may be an important therapeutic target for HCC, and the significance of MALAT1’s function in mitochondria requires further study [18].
Another nuclear-genome-encoded lncRNA, survival-associated mitochondrial melanoma-specific oncogenic non-coding RNA (SAMMSON), has been shown to localize in mitochondria in melanoma cells. In these cells, SAMMSON interacts with p32, a master regulator of mitochondrial homeostasis and metabolism, and facilitates the mitochondrial localization of p32. The silencing of SAMMSON decreases the expression levels of mtDNA-encoded ETC complex subunits and the activities of ETC complexes I and IV and suppresses tumorigenesis via enhancing apoptosis [94,95]. Meanwhile, a recent study showed that SAMMSON silencing increases the expression levels of ETC complexes, cellular respiration, and mitochondrial replication in doxorubicin-resistant MCF-7 cells [96]. This finding suggests context-dependent functions for SAMMSON, although further analysis is required to clarify the binding partners and molecular mechanism of this lncRNA.
In addition, it has been indicated that some mitochondria-associated lncRNAs function as miRNA sponges in order to modulate the expression of ETC complexes. For example, it has been suggested that the lncRNA potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1 (Kcnq1ot1) acts as a sponge for miR-378a and upregulates ATP6 expression and complex V activity in cardiomyocytes [97]. Another lncRNA, cytoplasmic endogenous regulator of oxidative phosphorylation 1 (Cerox1), binds to and inhibits miR-488-3p to enhance the expression of multiple ETC complex I subunits and mitochondrial respiration in N2A neuroblastoma cells [98].

6. Roles of Circular RNAs in the Regulation of Mitochondrial ETC Complexes

Recent studies have indicated that circRNAs can act as scaffolds in protein complex assembly, and some circRNAs regulate mitochondrial functions through direct binding to subunits of ETC complexes and complex V (Table 2 and Figure 3). For instance, the mitochondria-located circRNA circular RNA pumilio-1 (circPUM1) has been reported to act as a scaffold in order to regulate the spatial conformation of ETC complex III in KYSE30 and KYSE410 esophageal squamous cell carcinoma (ESCC) cells [99]. circPUM1 binds to ubiquinol cytochrome c reductase core protein 2 (UQCRC2) and modulates the formation of the UQCRC1-UQCRC2 dimer in mitochondrial complex III, which helps pump hydrogen from the mitochondrial matrix to the mitochondrial intermembrane space [124]. The silencing of circPUM1 leads to an intense interaction between UQCRC1 and UQCRC2, whereas circPUM1 overexpression disrupts it. Furthermore, circPUM1 silencing decreases ATP synthesis, whereas circPUM1 overexpression promotes it. Conversely, ROS levels are increased through circPUM1 silencing and decreased via circPUM1 overexpression. These findings suggest that circPUM1 plays a critical role in the proper assembly of the UQCRC1-UQCRC2 dimer and, therefore, OXPHOS. Intriguingly, circPUM1 silencing induces pyroptosis, a kind of programmed cell death, suggesting that this circRNA is a potential target of ESCC treatment. Furthermore, it has been reported that a circRNA regulates mitochondrial ROS output through interacting with a complex V subunit, namely, ATP5B [76]. Steatohepatitis-associated circRNA ATP5B regulator (SCAR) is a mitochondrial genome-encoded circRNA that is downregulated in fibroblasts of liver tissues from patients with non-alcoholic steatohepatitis (NASH) cirrhosis. SCAR binds to ATP5B, which acts as a regulator of the mitochondrial permeability transition pore (mPTP) complex. The SCAR–ATP5B complex blocks mPTP from cyclophilin D, a facilitator of mPTP opening, and shuts down mPTP, thereby inhibiting mitochondrial ROS output. Interestingly, circRNA SCAR alleviates high fat diet-induced cirrhosis in mice, suggesting that the manipulation of circRNA SCAR expression may be applicable to therapeutic strategies of NASH.
Moreover, mitochondrial circRNA for translocating phosphoglycerate kinase 1 (mcPGK1) has been indicated to be involved in metabolism reprogramming from OXPHOS to glycolysis. mcPGK1 promotes the mitochondrial import of a key glycolytic enzyme, PGK1, by facilitating the interaction between PGK1 and the translocase of outer mitochondrial membrane 40 (TOM40), which forms the central channel of the translocase of the mitochondrial outer membrane (TOM complex). mcPGK1 is highly expressed in primary liver tumor-initiating cells (TICs) and is involved in TIC self-renewal, indicating the significance of mcPGK1 in clinical management of liver cancer [100].

7. Conclusions

In the present review, we have described multiple classes of noncoding RNAs and their regulatory pathways involved in the mitochondrial electron transport chain and OXHPOS (Table 2 and Figure 3). Clarifying the mechanisms of the noncoding RNAs regulating the mitochondrial electron transport chain and OXHPOS will help identify therapeutic targets for various diseases such as MERRF, MELAS, and cardiomyopathy in which OXPHOS plays a crucial role. The identification of new noncoding RNAs affecting the mitochondrial electron transport chain, OXPHOS, and their related molecules will allow us to further understand pathophysiology of the diseases. Although some noncoding RNAs mentioned in this review can be targets for innovative treatment or prophylactic agents for OXPHOS-related conditions, they are still far from clinical application. Both basic and clinical research on noncoding RNAs and the pathways by which they regulate the mitochondrial electron transport chain and OXPHOS would be required for the discovery of novel therapeutic approaches for OXPHOS-related diseases.

Author Contributions

Conceptualization, A.K.; writing—original draft preparation, A.K.; writing—review and editing, T.T., K.I. and S.I.; supervision, S.I. All authors have read and agreed to the published version of the manuscript.

Funding

This work was partially supported by grants from the Japan Society for the Promotion of Science, Japan [23K08837 (to T.T.); 21H02981 and 22K19572 (to K.I.); and 21H04829 (to S.I.)] and by the Takeda Science Foundation (to K.I. and S.I.).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kobayashi, A.; Azuma, K.; Ikeda, K.; Inoue, S. Mechanisms Underlying the Regulation of Mitochondrial Respiratory Chain Complexes by Nuclear Steroid Receptors. Int. J. Mol. Sci. 2020, 21, 6683. [Google Scholar] [CrossRef]
  2. Schägger, H.; Pfeiffer, K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 2000, 19, 1777–1783. [Google Scholar] [CrossRef]
  3. Ikeda, K.; Shiba, S.; Horie-Inoue, K.; Shimokata, K.; Inoue, S. A stabilizing factor for mitochondrial respiratory supercomplex assembly regulates energy metabolism in muscle. Nat. Commun. 2013, 4, 2147. [Google Scholar] [CrossRef]
  4. Lapuente-Brun, E.; Moreno-Loshuertos, R.; Aciń-Pérez, R.; Latorre-Pellicer, A.; Colaś, C.; Balsa, E.; Perales-Clemente, E.; Quirós, P.M.; Calvo, E.; Rodríguez-Hernández, M.A.; et al. Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science 2013, 340, 1567–1570. [Google Scholar] [CrossRef]
  5. Genova, M.L.; Lenaz, G. Functional role of mitochondrial respiratory supercomplexes. Biochim. Biophys. Acta-Bioenerg. 2014, 1837, 427–443. [Google Scholar] [CrossRef] [PubMed]
  6. Kobayashi, A.; Azuma, K.; Takeiwa, T.; Kitami, T.; Horie, K.; Ikeda, K.; Inoue, S. A FRET-based respirasome assembly screen identifies spleen tyrosine kinase as a target to improve muscle mitochondrial respiration and exercise performance in mice. Nat. Commun. 2023, 14, 312. [Google Scholar] [CrossRef]
  7. Maranzana, E.; Barbero, G.; Falasca, A.I.; Lenaz, G.; Genova, M.L. Mitochondrial respiratory supercomplex association limits production of reactive oxygen species from complex I. Antioxid. Redox Signal 2013, 19, 1469–1480. [Google Scholar] [CrossRef]
  8. Lopez-Fabuel, I.; Le Douce, J.; Logan, A.; James, A.M.; Bonvento, G.; Murphy, M.P.; Almeida, A.; Bolaños, J.P. Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes. Proc. Natl. Acad. Sci. USA 2016, 113, 13063–13068. [Google Scholar] [CrossRef] [PubMed]
  9. Ikeda, K.; Horie-Inoue, K.; Suzuki, T.; Hobo, R.; Nakasato, N.; Takeda, S.; Inoue, S. Mitochondrial supercomplex assembly promotes breast and endometrial tumorigenesis by metabolic alterations and enhanced hypoxia tolerance. Nat. Commun. 2019, 10, 4108. [Google Scholar] [CrossRef] [PubMed]
  10. Schägger, H.; de Coo, R.; Bauer, M.F.; Hofmann, S.; Godinot, C.; Brandt, U. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J. Biol. Chem. 2004, 279, 36349–36353. [Google Scholar] [CrossRef]
  11. Boczonadi, V.; Ricci, G.; Horvath, R. Mitochondrial DNA transcription and translation: Clinical syndromes. Essays Biochem. 2018, 62, 321–340. [Google Scholar]
  12. Rötig, A. Human diseases with impaired mitochondrial protein synthesis. Biochim. Biophys. Acta 2011, 1807, 1198–1205. [Google Scholar] [CrossRef]
  13. DiMauro, S.; Schon, E.A.; Carelli, V.; Hirano, M. The clinical maze of mitochondrial neurology. Nat. Rev. Neurol. 2013, 9, 429–444. [Google Scholar] [CrossRef] [PubMed]
  14. Fernandez-Vizarra, E.; Zeviani, M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021, 595, 1062–1106. [Google Scholar] [CrossRef] [PubMed]
  15. Bhatti, J.S.; Bhatti, G.K.; Reddy, P.H. Mitochondrial dysfunction and oxidative stress in metabolic disorders—A step towards mitochondria based therapeutic strategies. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 1066–1077. [Google Scholar] [CrossRef] [PubMed]
  16. Reinecke, F.; Smeitink, J.A.M.; van der Westhuizen, F.H. OXPHOS gene expression and control in mitochondrial disorders. Biochim. Biophys. Acta 2009, 1792, 1113–1121. [Google Scholar] [CrossRef]
  17. Das, S.; Ferlito, M.; Kent, O.A.; Fox-Talbot, K.; Wang, R.; Liu, D.; Raghavachari, N.; Yang, Y.; Wheelan, S.J.; Murphy, E.; et al. Nuclear miRNA regulates the mitochondrial genome in the heart. Circ. Res. 2012, 110, 1596–1603. [Google Scholar] [CrossRef]
  18. Zhao, Y.; Zhou, L.; Li, H.; Sun, T.; Wen, X.; Li, X.; Meng, Y.; Li, Y.; Liu, M.; Liu, S.; et al. Nuclear-Encoded lncRNA MALAT1 Epigenetically Controls Metabolic Reprogramming in HCC Cells through the Mitophagy Pathway. Mol. Ther. Nucleic Acids 2020, 23, 264–276. [Google Scholar] [CrossRef] [PubMed]
  19. Hyttinen, J.M.T.; Blasiak, J.; Kaarniranta, K. Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD). Int. J. Mol. Sci. 2023, 24, 2636. [Google Scholar] [CrossRef]
  20. Kamada, S.; Takeiwa, T.; Ikeda, K.; Horie-Inoue, K.; Inoue, S. Long Noncoding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers. Front. Oncol. 2020, 10, 593200. [Google Scholar] [CrossRef] [PubMed]
  21. Treiber, T.; Treiber, N.; Meister, G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat. Rev. Mol. Cell Biol. 2019, 20, 5–20. [Google Scholar] [CrossRef] [PubMed]
  22. Carthew, R.W.; Sontheimer, E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136, 642–655. [Google Scholar] [CrossRef] [PubMed]
  23. Chekulaeva, M.; Filipowicz, W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 2009, 21, 452–460. [Google Scholar] [CrossRef]
  24. Czech, B.; Hannon, G.J. Small RNA sorting: Matchmaking for Argonautes. Nat. Rev. Genet. 2011, 12, 19–31. [Google Scholar] [CrossRef]
  25. Iwakawa, H.O.; Tomari, Y. The Functions of MicroRNAs: MRNA Decay and Translational Repression. Trends Cell Biol. 2015, 25, 651–665. [Google Scholar] [CrossRef] [PubMed]
  26. Liu, H.; Lei, C.; He, Q.; Pan, Z.; Xiao, D.; Tao, Y. Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol. Cancer 2018, 17, 64. [Google Scholar] [CrossRef]
  27. Ni, W.J.; Leng, X.M. miRNA-Dependent Activation of mRNA Translation. MicroRNA 2016, 5, 83–86. [Google Scholar] [CrossRef]
  28. Barrey, E.; Saint-Auret, G.; Bonnamy, B.; Damas, D.; Boyer, O.; Gidrol, X. Pre-microRNA and Mature microRNA in Human Mitochondria. PLoS ONE 2011, 6, e20220. [Google Scholar] [CrossRef]
  29. Bandiera, S.; Matégot, R.; Girard, M.; Demongeot, J.; Henrion- Caude, A. MitomiRs delineating the intracellular localization of microRNAs at mitochondria. Free Radic. Biol. Med. 2013, 64, 12–19. [Google Scholar] [CrossRef]
  30. Thompson, D.M.; Lu, C.; Green, P.J.; Parker, R. tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA 2008, 14, 2095–2103. [Google Scholar] [CrossRef]
  31. Thompson, D.M.; Parker, R. Stressing out over tRNA cleavage. Cell 2009, 138, 215–219. [Google Scholar] [CrossRef]
  32. Haussecker, D.; Huang, Y.; Lau, A.; Parameswaran, P.; Fire, A.Z.; Kay, M.A. Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA 2010, 16, 673–695. [Google Scholar] [CrossRef]
  33. Pederson, T. Regulatory RNAs derived from transfer RNA? RNA 2010, 16, 1865–1869. [Google Scholar] [CrossRef]
  34. Garcia-Silva, M.R.; Cabrera-Cabrera, F.; Güida, M.C.; Cayota, A. Hints of tRNA-Derived Small RNAs Role in RNA Silencing Mechanisms. Genes 2012, 3, 603–614. [Google Scholar] [CrossRef] [PubMed]
  35. Saikia, M.; Krokowski, D.; Guan, B.J.; Ivanov, P.; Parisien, M.; Hu, G.F.; Anderson, P.; Pan, T.; Hatzoglou, M. Genome-wide Identification and Quantitative Analysis of Cleaved tRNA Fragments Induced by Cellular Stress. J. Biol. Chem. 2012, 287, 42708–42725. [Google Scholar] [CrossRef]
  36. Gebetsberger, J.; Polacek, N. Slicing tRNAs to boost functional ncRNA diversity. RNA Biol. 2013, 10, 1798–1806. [Google Scholar] [CrossRef] [PubMed]
  37. Wang, Q.; Lee, I.; Ren, J.; Ajay, S.S.; Lee, Y.S.; Bao, X. Identification and functional characterization of tRNA-derived RNA fragments (tRFs) in respiratory syncytial virus infection. Mol. Ther. 2013, 21, 368–379. [Google Scholar] [CrossRef] [PubMed]
  38. Ro, S.; Ma, H.Y.; Park, C.; Ortogero, N.; Song, R.; Hennig, G.W.; Zheng, H.; Lin, Y.M.; Moro, L.; Hsieh, J.T.; et al. The mitochondrial genome encodes abundant small noncoding RNAs. Cell Res. 2013, 23, 759–774. [Google Scholar] [CrossRef]
  39. Telonis, A.G.; Loher, P.; Honda, S.; Jing, Y.; Palazzo, J.; Kirino, Y.; Rigoutsos, I. Dissecting tRNA-derived fragment complexities using personalized transcriptomes reveals novel fragment classes and unexpected dependencies. Oncotarget 2015, 6, 24797–24822. [Google Scholar] [CrossRef] [PubMed]
  40. Telonis, A.G.; Kirino, Y.; and Rigoutsos, I. Mitochondrial tRNA- look alikes in nuclear chromosomes: Could they be functional? RNA Biol. 2015, 12, 375–380. [Google Scholar] [CrossRef]
  41. Olvedy, M.; Scaravilli, M.; Hoogstrate, Y.; Visakorpi, T.; Jenster, G.; Martens- Uzunova, E.S. A comprehensive repertoire of tRNA-derived fragments in prostate cancer. Oncotarget 2016, 7, 24766–24777. [Google Scholar] [CrossRef] [PubMed]
  42. Pliatsika, V.; Loher, P.; Telonis, A.G.; Rigoutsos, I. MINTbase: A framework for the interactive exploration of mitochondrial and nuclear tRNA fragments. Bioinformatics 2016, 32, 2481–2489. [Google Scholar] [CrossRef] [PubMed]
  43. Pliatsika, V.; Loher, P.; Magee, R.; Telonis, A.G.; Londin, E.; Shigematsu, M.; Kirino, Y.; Rigoutsos, I. MINTbase v2. 0: A comprehensive database for tRNA- derived fragments that includes nuclear and mitochondrial fragments from all The Cancer Genome Atlas projects. Nucleic Acids Res. 2018, 46, D152–D159. [Google Scholar]
  44. Lant, J.T.; Berg, M.D.; Heinemann, I.U.; Brandl, C.J.; O’Donoghue, P. Pathways to disease from natural variations in human cytoplasmic tRNAs. J. Biol. Chem. 2019, 294, 5294–5308. [Google Scholar] [CrossRef]
  45. Salinas-Giegé, T.; Giegé, R.; Giegé, P. tRNA Biology in Mitochondria. Int. J. Mol. Sci. 2015, 16, 4518–4559. [Google Scholar] [CrossRef]
  46. Lei, H.T.; Wang, Z.H.; Li, B.; Sun, Y.; Mei, S.Q.; Yang, J.H.; Qu, L.H.; Zheng, L.L. tModBase: Deciphering the landscape of tRNA modifications and their dynamic changes from epitranscriptome data. Nucleic Acids Res. 2023, 51, D315–D327. [Google Scholar] [CrossRef] [PubMed]
  47. Pan, T. Modifications and functional genomics of human transfer RNA. Cell Res. 2018, 28, 395–404. [Google Scholar] [CrossRef]
  48. Lyons, S.M.; Fay, M.M.; Ivanov, P. The role of RNA modifications in the regulation of tRNA cleavage. FEBS Lett. 2018, 592, 2828–2844. [Google Scholar] [CrossRef]
  49. Tao, E.W.; Cheng, W.Y.; Li, W.L.; Yu, J.; Gao, Q.Y. tiRNAs: A novel class of small noncoding RNAs that helps cells respond to stressors and plays roles in cancer progression. J Cell Physiol. 2020, 235, 683–690. [Google Scholar] [CrossRef] [PubMed]
  50. Yang, J.Y.; Deng, X.Y.; Li, Y.S.; Ma, X.C.; Feng, J.X.; Yu, B.; Chen, Y.; Luo, Y.L.; Wang, X.; Chen, M.L.; et al. Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control. Nat. Commun. 2018, 9, 1165. [Google Scholar] [CrossRef]
  51. Kumar, P.; Anaya, J.; Mudunuri, S.B.; Dutta, A. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets. BMC Biol. 2014, 12, 78. [Google Scholar] [CrossRef] [PubMed]
  52. Skeparnias, I.; Anastasakis, D.; Grafanaki, K.; Kyriakopoulos, G.; Alexopoulos, P.; Dougenis, D.; Scorilas, A.; Kontos, C.K.; Stathopoulos, C. Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer. Cancers 2020, 12, 3056. [Google Scholar] [CrossRef] [PubMed]
  53. Kumar, P.; Mudunuri, S.B.; Anaya, J.; Dutta, A. tRFdb: A database for transfer RNA fragments. Nucleic Acids Res. 2015, 43, D141–D145. [Google Scholar] [CrossRef]
  54. Zheng, L.L.; Xu, W.L.; Liu, S.; Sun, W.J.; Li, J.H.; Wu, J.; Yang, J.H.; Qu, L.H. tRF2Cancer: A web server to detect tRNA-derived small RNA fragments (tRFs) and their expression in multiple cancers. Nucleic Acids Res. 2016, 44, W185–W193. [Google Scholar] [CrossRef]
  55. Looney, M.M.; Lu, Y.; Karakousis, P.C.; Halushka, M.K. Mycobacterium tuberculosis Infection Drives Mitochondria-Biased Dysregulation of Host Transfer RNA–Derived Fragments. J. Infect. Dis. 2021, 223, 1796–1805. [Google Scholar] [CrossRef]
  56. Loher, P.; Telonis, A.G.; Rigoutsos, I. MINTmap: Fast and exhaustive profiling of nuclear and mitochondrial tRNA fragments from short RNA-seq data. Sci. Rep. 2017, 7, 41184. [Google Scholar] [CrossRef]
  57. Meseguer, S.; Navarro-González, C.; Panadero, J.; Villarroya, M.; Boutoual, R.; Sánchez-Alcázar, J.A.; Armengod, M.E. The MELAS mutation m.3243A>G alters the expression of mitochondrial tRNA fragments. Biochim. Biophys. Acta Mol. Cell Res. 2019, 1866, 1433–1449.
  58. Slack, F.J.; Chinnaiyan, A.M. The Role of Non-coding RNAs in Oncology. Cell 2019, 179, 1033–1055. [Google Scholar] [CrossRef]
  59. Mitobe, Y.; Takayama, K.I.; Horie-Inoue, K.; Inoue, S. Prostate cancer-associated lncRNAs. Cancer Lett. 2018, 418, 159–166. [Google Scholar] [CrossRef] [PubMed]
  60. Takeiwa, T.; Ikeda, K.; Mitobe, Y.; Horie-Inoue, K.; Inoue, S. Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer. Cancers 2020, 12, 1424. [Google Scholar] [CrossRef]
  61. Takeiwa, T.; Ikeda, K.; Horie-Inoue, K.; Inoue, S. Mechanisms of Apoptosis-Related Long Noncoding RNAs in Ovarian Cancer. Front. Cell Dev. Biol. 2021, 9, 641963. [Google Scholar] [CrossRef]
  62. Noh, J.H.; Kim, K.M.; Abdelmohsen, K.; Yoon, J.H.; Panda, A.C.; Munk, R.; Kim, J.; Curtis, J.; Moad, C.A.; Wohler, C.M.; et al. HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP. Genes Dev. 2016, 30, 1224–1239. [Google Scholar] [CrossRef]
  63. Li, K.; Smagula, C.S.; Parsons, W.J.; Richardson, J.A.; Gonzalez, M.; Hagler, H.K.; Williams, R.S. Subcellular partitioning of MRP RNA assessed by ultrastructural and biochemical analysis. J. Cell Biol. 1994, 124, 871–882. [Google Scholar] [CrossRef]
  64. Jeandard, D.; Smirnova, A.; Tarassov, I.; Barrey, E.; Smirnov, A.; Entelis, N. Import of Non-Coding RNAs into Human Mitochondria: A Critical Review and Emerging Approaches. Cells 2019, 8, 286. [Google Scholar] [CrossRef]
  65. Gammage, P.A.; Frezza, C. Mitochondrial DNA: The overlooked oncogenome? BMC Biol. 2019, 17, 53. [Google Scholar] [CrossRef]
  66. Jeck, W.R.; Sorrentino, J.A.; Wang, K.; Slevin, M.K.; Burd, C.E.; Liu, J.; Marzluff, W.F.; Sharpless, N.E. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013, 19, 141–157. [Google Scholar] [CrossRef]
  67. Salzman, J.; Chen, R.E.; Olsen, M.N.; Wang, P.L.; Brown, P.O. Cell-type specific features of circular RNA expression. PLoS Genet. 2013, 9, e1003777. [Google Scholar] [CrossRef]
  68. Chen, L.L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 2016, 17, 205–211. [Google Scholar] [CrossRef] [PubMed]
  69. Kristensen, L.S.; Andersen, M.S.; Stagsted, L.V.W.; Ebbesen, K.K.; Hansen, T.B.; Kjems, J. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet. 2019, 20, 675–691. [Google Scholar] [CrossRef] [PubMed]
  70. Piwecka, M.; Glažar, P.; Hernandez-Miranda, L.R.; Memczak, S.; Wolf, S.A.; Rybak-Wolf, A.; Filipchyk, A.; Klironomos, F.; Cerda Jara, C.A.; Fenske, P.; et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science 2017, 357, eaam8526. [Google Scholar] [CrossRef]
  71. Wilusz, J.E. A 360° view of circular RNAs: From biogenesis to functions. Wiley Interdiscip. Rev. RNA 2018, 9, e1478. [Google Scholar] [CrossRef] [PubMed]
  72. Jeck, W.R.; Sharpless, N.E. Detecting and characterizing circular RNAs. Nat. Biotechnol. 2014, 32, 453–461. [Google Scholar] [CrossRef]
  73. Chen, L.L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat. Rev. Mol. Cell Biol. 2020, 21, 475–490. [Google Scholar] [CrossRef]
  74. Xiao, M.S.; Ai, Y.; Wilusz, J.E. Biogenesis and Functions of Circular RNAs Come into Focus. Trends Cell Biol. 2020, 30, 226–240. [Google Scholar] [CrossRef]
  75. Salzman, J.; Gawad, C.; Wang, P.L.; Lacayo, N.; Brown, P.O. Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types. PLoS ONE 2012, 7, e30733. [Google Scholar] [CrossRef]
  76. Zhao, Q.; Liu, J.; Deng, H.; Ma, R.; Liao, J.Y.; Liang, H.; Hu, J.; Li, J.; Guo, J.; Cai, J.; et al. Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output. Cell 2020, 183, 76–93. [Google Scholar] [CrossRef] [PubMed]
  77. Wu, Z.; Sun, H.; Wang, C.; Liu, W.; Liu, M.; Zhu, Y.; Xu, W.; Jin, H.; Li, J. Mitochondrial Genome-Derived circRNA mc-COX2 Functions as an Oncogene in Chronic Lymphocytic Leukemia. Mol. Ther. Nucleic. Acids 2020, 20, 801–811. [Google Scholar] [CrossRef]
  78. Liu, X.; Wang, X.; Li, J.; Hu, S.; Deng, Y.; Yin, H.; Bao, X.; Zhang, Q.C.; Wang, G.; Wang, B.; et al. Identification of mecciRNAs and their roles in the mitochondrial entry of proteins. Sci. China Life Sci. 2020, 63, 1429–1449. [Google Scholar] [CrossRef] [PubMed]
  79. Liang, H.; Liu, J.; Su, S.; Zhao, Q. Mitochondrial noncoding RNAs: New wine in an old bottle. RNA Biol. 2021, 18, 2168–2182. [Google Scholar] [CrossRef] [PubMed]
  80. Cavalcante, G.C.; Magalhães, L.; Ribeiro-Dos-Santos, Â.; Vidal, A.F. Mitochondrial Epigenetics: Noncoding RNAs as a Novel Layer of Complexity. Int. J. Mol. Sci. 2020, 21, 1838. [Google Scholar] [CrossRef] [PubMed]
  81. Sharma, P.; Sharma, V.; Ahluwalia, T.S.; Dogra, N.; Kumar, S.; Singh, S. Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4. Cancer Cell Int. 2021, 21, 629. [Google Scholar] [CrossRef]
  82. Yan, K.; An, T.; Zhai, M.; Huang, Y.; Wang, Q.; Wang, Y.; Zhang, R.; Wang, T.; Liu, J.; Zhang, Y.; et al. Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2. Cell Death Dis. 2019, 10, 500. [Google Scholar] [CrossRef] [PubMed]
  83. Jagannathan, R.; Thapa, D.; Nichols, C.E.; Shepherd, D.L.; Stricker, J.C.; Croston, T.L.; Baseler, W.A.; Lewis, S.E.; Martinez, I.; Hollander, J.M. Translational Regulation of the Mitochondrial Genome Following Redistribution of Mitochondrial MicroRNA in the Diabetic Heart. Circ. Cardiovasc. Genet. 2015, 8, 785–802. [Google Scholar] [CrossRef] [PubMed]
  84. Shepherd, D.L.; Hathaway, Q.A.; Pinti, M.V.; Nichols, C.E.; Durr, A.J.; Sreekumar, S.; Hughes, K.M.; Stine, S.M.; Martinez, I.; Hollander, J.M. Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase). J. Mol. Cell Cardiol. 2017, 110, 15–25. [Google Scholar] [CrossRef]
  85. Li, H.; Zhang, X.; Wang, F.; Zhou, L.; Yin, Z.; Fan, J.; Nie, X.; Wang, P.; Fu, X.D.; Chen, C.; et al. MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial Translation. Circulation 2016, 134, 734–751. [Google Scholar] [CrossRef]
  86. Zhang, X.; Zuo, X.; Yang, B.; Li, Z.; Xue, Y.; Zhou, Y.; Huang, J.; Zhao, X.; Zhou, J.; Yan, Y.; et al. MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation. Cell 2014, 158, 607–619. [Google Scholar] [CrossRef]
  87. Chen, W.; Wang, P.; Lu, Y.; Jin, T.; Lei, X.; Liu, M.; Zhuang, P.; Liao, J.; Lin, Z.; Li, B.; et al. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation. Theranostics 2019, 9, 5739–5754. [Google Scholar] [CrossRef] [PubMed]
  88. Fan, S.; Tian, T.; Chen, W.; Lv, X.; Lei, X.; Zhang, H.; Sun, S.; Cai, L.; Pan, G.; He, L.; et al. Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription. Cancer Res. 2019, 79, 1069–1084. [Google Scholar] [CrossRef] [PubMed]
  89. Aschrafi, A.; Schwechter, A.D.; Mameza, M.G.; Natera-Naranjo, O.; Gioio, A.E.; Kaplan, B.B. MicroRNA-338 Regulates Local Cytochrome c Oxidase IV mRNA Levels and Oxidative Phosphorylation in the Axons of Sympathetic Neurons. J. Neurosci. 2008, 28, 12581–12590. [Google Scholar] [CrossRef] [PubMed]
  90. Chen, Z.; Li, Y.; Zhang, H.; Huang, P.; Luthra, R. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 2010, 29, 4362–4368. [Google Scholar] [CrossRef] [PubMed]
  91. Zheng, S.Q.; Li, Y.X.; Zhang, Y.; Li, X.; Tang, H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res. 2011, 89, 219–226. [Google Scholar] [CrossRef]
  92. Carden, T.; Singh, B.; Mooga, V.; Bajpai, P.; Singh, K.K. Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression. J. Biol. Chem. 2017, 292, 20694–20706. [Google Scholar] [CrossRef] [PubMed]
  93. Bayazit, M.B.; Jacovetti, C.; Cosentino, C.; Sobel, J.; Wu, K.; Brozzi, F.; Rodriguez-Trejo, A.; Stoll, L.; Guay, C.; Regazzi, R. Small RNAs derived from tRNA fragmentation regulate the functional maturation of neonatal β cells. Cell Rep. 2022, 40, 111069. [Google Scholar] [CrossRef] [PubMed]
  94. Leucci, E.; Vendramin, R.; Spinazzi, M.; Laurette, P.; Fiers, M.; Wouters, J.; Radaelli, E.; Eyckerman, S.; Leonelli, C.; Vanderheyden, K.; et al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature 2016, 531, 518–522. [Google Scholar] [CrossRef] [PubMed]
  95. Dewaele, S.; Delhaye, L.; De Paepe, B.; de Bony, E.J.; De Wilde, J.; Vanderheyden, K.; Anckaert, J.; Yigit, N.; Nuytens, J.; Eynde, E.V.; et al. The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival. Oncogene 2022, 41, 15–25. [Google Scholar] [CrossRef] [PubMed]
  96. Orre, C.; Dieu, X.; Guillon, J.; Gueguen, N.; Ahmadpour, S.T.; Dumas, J.F.; Khiati, S.; Reynier, P.; Lenaers, G.; Coqueret, O.; et al. The Long Non-Coding RNA SAMMSON Is a Regulator of Chemosensitivity and Metabolic Orientation in MCF-7 Doxorubicin-Resistant Breast Cancer Cells. Biology 2021, 10, 1156. [Google Scholar] [CrossRef]
  97. Durr, A.J.; Hathaway, Q.A.; Kunovac, A.; Taylor, A.D.; Pinti, M.V.; Rizwan, S.; Shepherd, D.L.; Cook, C.C.; Fink, G.K.; Hollander, J.M. Manipulation of the miR-378a/mt-ATP6 regulatory axis rescues ATP synthase in the diabetic heart and offers a novel role for lncRNA Kcnq1ot1. Am. J. Physiol. Cell Physiol. 2022, 322, C482–C495. [Google Scholar] [CrossRef]
  98. Sirey, T.M.; Roberts, K.; Haerty, W.; Bedoya-Reina, O.; Rogatti-Granados, S.; Tan, J.Y.; Li, N.; Heather, L.C.; Carter, R.N.; Cooper, S.; et al. The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity. eLife 2019, 8, e45051. [Google Scholar] [CrossRef]
  99. Gong, W.; Xu, J.; Wang, Y.; Min, Q.; Chen, X.; Zhang, W.; Chen, J.; Zhan, Q. Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma. Signal Transduct. Target. Ther. 2022, 7, 40. [Google Scholar] [CrossRef]
  100. Chen, Z.; He, Q.; Lu, T.; Wu, J.; Shi, G.; He, L.; Zong, H.; Liu, B.; Zhu, P. mcPGK1-dependent mitochondrial import of PGK1 promotes metabolic reprogramming and self-renewal of liver TICs. Nat. Commun. 2023, 14, 1121. [Google Scholar] [CrossRef]
  101. Das, S.; Bedja, D.; Campbell, N.; Dunkerly, B.; Chenna, V.; Maitra, A.; Steenbergen, C. miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo. PLoS ONE 2014, 9, e96820. [Google Scholar] [CrossRef]
  102. Gevaert, A.B.; Witvrouwen, I.; Van Craenenbroeck, A.H.; Van Laere, S.J.; Boen, J.R.A.; Van de Heyning, C.M.; Belyavskiy, E.; Mueller, S.; Winzer, E.; Duvinage, A.; et al. miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: An analysis of the OptimEx-Clin trial. Eur. J. Prev. Cardiol. 2021, 28, 1722–1733. [Google Scholar] [CrossRef]
  103. Meseguer, S.; Martínez-Zamora, A.; García-Arumí, E.; Andreu, A.L.; Armengod, M.E. The ROS-sensitive microRNA-9/9∗ controls the expression of mitochondrial tRNA-modifying enzymes and is involved in the molecular mechanism of MELAS syndrome. Hum. Mol. Genet. 2015, 24, 167–184. [Google Scholar] [CrossRef] [PubMed]
  104. Meseguer, S.; Boix, O.; Navarro-González, C.; Villarroya, M.; Boutoual, R.; Emperador, S.; García-Arumí, E.; Montoya, J.; Armengod, M.E. microRNA-mediated differential expression of TRMU, GTPBP3 and MTO1 in cell models of mitochondrial-DNA diseases. Sci. Rep. 2017, 7, 6209. [Google Scholar] [CrossRef] [PubMed]
  105. Wang, W.; Zhuang, Q.; Ji, K.; Wen, B.; Lin, P.; Zhao, Y.; Li, W.; Yan, C. Identification of miRNA, lncRNA and mRNA-associated ceRNA networks and potential biomarker for MELAS with mitochondrial DNA A3243G mutation. Sci. Rep. 2017, 7, 41639. [Google Scholar] [CrossRef]
  106. Meseguer, S.; Panadero, J.; Navarro-González, C.; Villarroya, M.; Boutoual, R.; Comi, G.P.; Armengod, M.E. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs. Biochim. Biophys. Acta Mol. Basis Dis. 2018, 1864, 3022–3037. [Google Scholar] [CrossRef]
  107. Anderson, S.; Bankier, A.T.; Barrell, B.G.; de Bruijn, M.H.; Coulson, A.R.; Drouin, J.; Eperon, I.C.; Nierlich, D.P.; Roe, B.A.; Sanger, F.; et al. Sequence and organization of the human mitochondrial genome. Nature 1981, 290, 457–465. [Google Scholar] [CrossRef]
  108. Gorman, G.S.; Chinnery, P.F.; DiMauro, S.; Hirano, M.; Koga, Y.; McFarland, R.; Suomalainen, A.; Thorburn, D.R.; Zeviani, M.; Turnbull, D.M. Mitochondrial diseases. Nat. Rev. Dis. Prim. 2016, 2, 16080. [Google Scholar] [CrossRef]
  109. Chinnery, P.F.; Johnson, M.A.; Wardell, T.M.; Singh-Kler, R.; Hayes, C.; Brown, D.T.; Taylor, R.W.; Bindoff, L.A.; Turnbull, D.M. The epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol. 2000, 48, 188–193. [Google Scholar] [CrossRef] [PubMed]
  110. Majamaa, K.; Moilanen, J.S.; Uimonen, S.; Remes, A.M.; Salmela, P.I.; Kärppä, M.; Majamaa-Voltti, K.A.; Rusanen, H.; Sorri, M.; Peuhkurinen, K.J.; et al. Epidemiology of A3243G, the Mutation for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Strokelike Episodes: Prevalence of the Mutation in an Adult Population. Am. J. Hum. Genet. 1998, 63, 447–454. [Google Scholar] [CrossRef]
  111. Uusimaa, J.; Moilanen, J.S.; Vainionpää, L.; Tapanainen, P.; Lindholm, P.; Nuutinen, M.; Löppönen, T.; Mäki-Torkko, E.; Rantala, H.; Majamaa, K. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann. Neurol. 2007, 62, 278–287. [Google Scholar] [CrossRef] [PubMed]
  112. Fornuskova, D.; Brantova, O.; Tesarova, M.; Stiburek, L.; Honzik, T.; Wenchich, L.; Tietzeova, E.; Hansikova, H.; Zeman, J. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim. Biophys. Acta 2008, 1782, 317–325. [Google Scholar] [CrossRef] [PubMed]
  113. Dubeau, F.; De Stefano, N.; Zifkin, B.G.; Arnold, D.L.; Shoubridge, E.A. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu(UUR) A3243G mutation in a MELAS pedigree. Ann. Neurol. 2000, 47, 179–185. [Google Scholar] [CrossRef] [PubMed]
  114. Börner, G.V.; Zeviani, M.; Tiranti, V.; Carrara, F.; Hoffmann, S.; Gerbitz, K.D.; Lochmüller, H.; Pongratz, D.; Klopstock, T.; Melberg, A.; et al. Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum. Mol. Genet. 2000, 9, 467–475. [Google Scholar]
  115. Chomyn, A.; Enriquez, J.A.; Micol, V.; Fernandez-Silva, P.; Attardi, G. The Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episode Syndrome-associated Human Mitochondrial tRNALeu(UUR) Mutation Causes Aminoacylation Deficiency and Concomitant Reduced Association of mRNA with Ribosomes. J. Biol. Chem. 2000, 275, 19198–19209. [Google Scholar] [CrossRef] [PubMed]
  116. King, M.P.; Koga, Y.; Davidson, M.; Schon, E.A. Defects in Mitochondrial Protein Synthesis and Respiratory Chain Activity Segregate with the tRNALeu(UUR) Mutation Associated with Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Strokelike Episodes. Mol. Cell Biol. 1992, 12, 480–490. [Google Scholar] [CrossRef] [PubMed]
  117. El Meziane, A.; Lehtinen, S.K.; Hance, N.; Nijtmans, L.G.; Dunbar, D.; Holt, I.J.; Jacobs, H.T. A tRNA suppressor mutation in human mitochondria. Nat. Genet. 1998, 18, 350–353. [Google Scholar] [CrossRef]
  118. Park, H.; Davidson, E.; King, M.P. The Pathogenic A3243G Mutation in Human Mitochondrial tRNALeu(UUR) Decreases the Efficiency of Aminoacylation. Biochemistry 2003, 42, 958–964. [Google Scholar] [CrossRef] [PubMed]
  119. Schaefer, M.; Pollex, T.; Hanna, K.; Tuorto, F.; Meusburger, M.; Helm, M.; Lyko, F. RNA methylation by Dnmt2 protects transfer RNAs against stress- induced cleavage. Genes Dev. 2010, 24, 1590–1595. [Google Scholar] [CrossRef]
  120. Blanco, S.; Dietmann, S.; Flores, J.V.; Hussain, S.; Kutter, C.; Humphreys, P.; Lukk, M.; Lombard, P.; Treps, L.; Popis, M.; et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 2014, 33, 2020–2039. [Google Scholar] [CrossRef]
  121. Zhang, Y.; Zhang, X.; Shi, J.; Tuorto, F.; Li, X.; Liu, Y.; Liebers, R.; Zhang, L.; Qu, Y.; Qian, J.; et al. Dnmt2 mediates intergenerational transmission of paternally acquired metabolic disorders through sperm small non-coding RNAs. Nat. Cell Biol. 2018, 20, 535–540. [Google Scholar] [CrossRef]
  122. Chen, Z.; Qi, M.; Shen, B.; Luo, G.; Wu, Y.; Li, J.; Lu, Z.; Zheng, Z.; Dai, Q.; Wang, H. Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic Acids Res. 2019, 47, 2533–2545. [Google Scholar] [CrossRef] [PubMed]
  123. Rackham, O.; Shearwood, A.M.J.; Mercer, T.R.; Davies, S.M.K.; Mattick, J.S.; Filipovska, A. Long noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA 2011, 17, 2085–2093. [Google Scholar] [CrossRef] [PubMed]
  124. Fernandez-Vizarra, E.; Zeviani, M. Mitochondrial complex III Rieske Fe-S protein processing and assembly. Cell Cycle 2018, 17, 681–687. [Google Scholar] [CrossRef] [PubMed]
Ijms 24 09414 g001 550
Figure 1. Mitochondrial electron transport chain complexes, supercomplex, and OXPHOS. The mitochondrial electron transport chain (ETC) is operated by four enzymatic protein complexes in the inner mitochondrial membrane, i.e., complex I (NADH ubiquinone oxidoreductase/NADH dehydrogenase; CI), complex II (succinate ubiquinone oxidoreductase/succinate dehydrogenase; CII), complex III (ubiquinol cytochrome c oxidoreductase/cytochrome bc1 complex; CIII), and complex IV (cytochrome c oxidase; CIV). Complexes I–IV mediate electron transport in the sequence from NADH or FADH2 to molecular oxygen. Through the ETC, protons (H+) are transported across the inner mitochondrial membrane to the intermembrane space. The established proton gradient is used to generate ATP from ADP phosphorylation by complex V (ATP synthase; CV), which is known as electron transport-linked phosphorylation or oxidative phosphorylation (OXPHOS). A certain portion of the mitochondrial electron transport complexes form higher-order structures called ‘supercomplexes’. The supercomplex generated by one CI, two CIIIs, and one CIV has been termed the ‘respirasome’.
Figure 1. Mitochondrial electron transport chain complexes, supercomplex, and OXPHOS. The mitochondrial electron transport chain (ETC) is operated by four enzymatic protein complexes in the inner mitochondrial membrane, i.e., complex I (NADH ubiquinone oxidoreductase/NADH dehydrogenase; CI), complex II (succinate ubiquinone oxidoreductase/succinate dehydrogenase; CII), complex III (ubiquinol cytochrome c oxidoreductase/cytochrome bc1 complex; CIII), and complex IV (cytochrome c oxidase; CIV). Complexes I–IV mediate electron transport in the sequence from NADH or FADH2 to molecular oxygen. Through the ETC, protons (H+) are transported across the inner mitochondrial membrane to the intermembrane space. The established proton gradient is used to generate ATP from ADP phosphorylation by complex V (ATP synthase; CV), which is known as electron transport-linked phosphorylation or oxidative phosphorylation (OXPHOS). A certain portion of the mitochondrial electron transport complexes form higher-order structures called ‘supercomplexes’. The supercomplex generated by one CI, two CIIIs, and one CIV has been termed the ‘respirasome’.
Ijms 24 09414 g001
Ijms 24 09414 g002 550
Figure 2. Noncoding RNAs regulating mitochondria–nucleus crosstalk. According to their localization and genome origin, mitochondrial noncoding RNAs (mt-ncRNAs) can be classified into four types: (a) nuclear-genome-encoded mitochondria-located mt-ncRNAs, (b) mtDNA-encoded mitochondria-located mt-ncRNAs, (c) mtDNA-encoded nucleus/cytosol-located mt-ncRNAs, and (d) nuclear-genome-encoded nucleus/cytosol-located mt-ncRNAs (termed “mitochondria-associated noncoding RNAs”). mt-ncRNAs regulate the mitochondrial electron transport chain and OXPHOS, which coordinate the crosstalk between nucleus and mitochondria as well as mitochondria-associated noncoding RNAs.
Figure 2. Noncoding RNAs regulating mitochondria–nucleus crosstalk. According to their localization and genome origin, mitochondrial noncoding RNAs (mt-ncRNAs) can be classified into four types: (a) nuclear-genome-encoded mitochondria-located mt-ncRNAs, (b) mtDNA-encoded mitochondria-located mt-ncRNAs, (c) mtDNA-encoded nucleus/cytosol-located mt-ncRNAs, and (d) nuclear-genome-encoded nucleus/cytosol-located mt-ncRNAs (termed “mitochondria-associated noncoding RNAs”). mt-ncRNAs regulate the mitochondrial electron transport chain and OXPHOS, which coordinate the crosstalk between nucleus and mitochondria as well as mitochondria-associated noncoding RNAs.
Ijms 24 09414 g002
Ijms 24 09414 g003 550
Figure 3. Regulation of mitochondrial ETC and OXPHOS by ncRNAs. The roles of the ncRNAs listed in Table 2 in mitochondrial ETC and OXPHOS are illustrated herein. miRNAs, tRFs, lncRNAs, and circRNAs are represented in blue, red, green, and orange, respectively. Ndufa1, NADH ubiquinone oxidoreductase subunit A1; Ndufa2, NADH ubiquinone oxidoreductase subunit A2; Ndufa3, NADH ubiquinone oxidoreductase subunit A3; Ndufab1, NADH ubiquinone oxidoreductase subunit AB1; Ndufb4, NADH ubiquinone oxidoreductase subunit B4; Ndufb9, NADH ubiquinone oxidoreductase subunit B9; Ndufc1, NADH ubiquinone oxidoreductase subunit C1; Ndufs1, NADH ubiquinone oxidoreductase core subunit S1; Ndufs3, NADH ubiquinone oxidoreductase core subunit S3; Ndufs4, NADH ubiquinone oxidoreductase subunit S4; Ndufs6, NADH ubiquinone oxidoreductase subunit S6; Ndufs8, NADH ubiquinone oxidoreductase core subunit S8; TOM, translocase of the mitochondrial outer membrane; TOM40, translocase of outer mitochondrial membrane 40.
Figure 3. Regulation of mitochondrial ETC and OXPHOS by ncRNAs. The roles of the ncRNAs listed in Table 2 in mitochondrial ETC and OXPHOS are illustrated herein. miRNAs, tRFs, lncRNAs, and circRNAs are represented in blue, red, green, and orange, respectively. Ndufa1, NADH ubiquinone oxidoreductase subunit A1; Ndufa2, NADH ubiquinone oxidoreductase subunit A2; Ndufa3, NADH ubiquinone oxidoreductase subunit A3; Ndufab1, NADH ubiquinone oxidoreductase subunit AB1; Ndufb4, NADH ubiquinone oxidoreductase subunit B4; Ndufb9, NADH ubiquinone oxidoreductase subunit B9; Ndufc1, NADH ubiquinone oxidoreductase subunit C1; Ndufs1, NADH ubiquinone oxidoreductase core subunit S1; Ndufs3, NADH ubiquinone oxidoreductase core subunit S3; Ndufs4, NADH ubiquinone oxidoreductase subunit S4; Ndufs6, NADH ubiquinone oxidoreductase subunit S6; Ndufs8, NADH ubiquinone oxidoreductase core subunit S8; TOM, translocase of the mitochondrial outer membrane; TOM40, translocase of outer mitochondrial membrane 40.
Ijms 24 09414 g003
Table
Table 1. Classification of noncoding RNAs (ncRNAs) related to mitochondria.
Table 1. Classification of noncoding RNAs (ncRNAs) related to mitochondria.
Noncoding RNAs (ncRNAs) Related to MitochondriaDefinitionGenomeLocation
miRNA (~22 nt)
mt-miRNAsmtDNA-encoded miRNAs or
miRNAs located in mitochondria		NuclearMitochondria
MitochondrialMitochondria or other compartments
MitomiRsMitochondria-located miRNAsNuclear or MitochondrialMitochondria
Mitochondria-associated miRNAsmiRNAs that are neither located in mitochondria nor encoded by mtDNA but regulate mitochondrial functionsNuclearNot located in mitochondria
tRNA-derived fragments (tRFs) (16–35 nt)
mt-tRFsmtDNA-encoded tRFs or
tRFs located in mitochondria		NuclearMitochondria
MitochondrialMitochondria or other compartments
Mitochondria-associated tRFstRFs that are neither located in mitochondria nor encoded by mtDNA but regulate mitochondrial functionsNuclearNot located in mitochondria
Long noncoding RNAs (lncRNAs) (>200 nt)
mt-lncRNAsmtDNA-encoded lncRNAs or
lncRNAs located in mitochondria		NuclearMitochondria
MitochondrialMitochondria or other compartments
Mitochondria-associated lncRNAslncRNAs that are neither located in mitochondria nor encoded by mtDNA but regulate mitochondrial functionsNuclearNot located in mitochondria
Circular RNAs (circRNAs)
mt-circRNAsmtDNA-encoded cicRNAs or
circRNAs located in mitochondria		NuclearMitochondria
MitochondrialMitochondria or other compartments
Mitochondria-associated circRNAscircRNAs that are neither located in mitochondria nor encoded by mtDNA but regulate mitochondrial functionsNuclearNot located in mitochondria
Table
Table 2. Roles of ncRNAs in regulation of mitochondrial ETC and OXPHOS.
Table 2. Roles of ncRNAs in regulation of mitochondrial ETC and OXPHOS.
ncRNASpeciesGenomeRoles in Mitochondrial ETC and OXPHOS
miRNAs
mitomiRs
let-7aHumanNuclearDecreases complex I activity by destabilizing ND4 mRNA in MCF-7 breast cancer cells [81]
miR-762MouseNuclearDecreases complex I activity through decreasing ND2 in murine cardiomyocytes upon anoxia/reoxygenation treatment [82]
miR-181cRatNuclearInduces complex IV remodeling and increases ROS levels by suppressing COX1 translation in rat cardiomyocytes [17]
miR-378aMouseNuclearDecreases a complex V subunit, ATP6, in IFM of a mouse model of type I diabetes mellitus [83]
Downregulates ATP6 expression in SSM of a mouse model of type II diabetes mellitus (db/db mice) [84]
miR-21RatNuclearPromotes CYTB translation in H9c2 rat cardiomyocytes and in hearts of spontaneous hypertensive rats [85]
miR-1MouseNuclearPromotes the translation of COX1 and ND1 in mouse C2C12 myoblasts [86]
miR-5787HumanNuclearPromotes COX3 translation and is involved in metabolic reprogramming and cisplatin resistance in Cal27 and Scc25 TSCC cells [87]
miR-2392HumanNuclearDecreases the mtDNA-encoded ETC complex subunits by repressing polycistronic mtDNA transcription and enhances anaerobic respiration in Cal27 and Scc9 TSCC cells [88]
Mitochondria-associated miRNAs
miR-338RatNuclearDecreases the expression of COX4 to reduce mitochondrial oxygen consumption in superior cervical ganglia (SCG) neurons [89]
miR-210HumanNuclearModulates mitochondrial function during hypoxia conditions by reducing expression levels of COX10 in HCT116 colon cancer cells [90]
miR-101HumanNuclearInhibits the replication of herpes simplex virus-1 (HSV-1) by downregulating the expression of ATP5B [91]
miR-663HumanNuclearIncreases the number of ETC complex (I, II, III, and IV) subunits and assembly factors, thereby stabilizing the ETC supercomplexes in MCF-7 breast cancer cells [92]
tRFs
mt-tRFs
mt-i-tRF Glu(UUC)HumanMitochondrialDownregulates MPC1 and increases extracellular lactate levels in MELAS cybrid cells [57]
tiRNA-5His(GTG)RatNuclearDecreases MPC1 and is involved in proliferation and insulin secretion of neonatal rat pancreatic β cells [93]
tiRNA-5Glu(CTC)RatNuclearDecreases MPC1 and is involved in proliferation and insulin secretion of neonatal rat pancreatic β cells [93]
Mitochondria-associated tRFs
tiRNA-5Glu(TTC)RatNuclearDecreases MPC1 levels and is involved in mitochondrial respiration, proliferation, and insulin secretion of neonatal rat pancreatic β cells [93]
lncRNA
mt-lncRNAs
MALAT1HumanNuclearModulates the CpG methylation of mtDNA and the expression of mtDNA-encoded ETC-related genes in HepG2 HCC cells [18]
SAMMSONHumanNuclearModulates the expression of mtDNA-encoded ETC complex subunits by facilitating mitochondrial localization of p32 in melanoma cells [94,95]
SAMMSON silencing increases the expression of ETC complexes, cellular respiration, and mitochondrial replication in doxorubicin-resistant MCF-7 breast cancer cells [96]
Mitochondria-associated lncRNAs
Kcnq1ot1MouseNuclearInhibits miR-378a to upregulate the ATP6 expression and complex V activity in murine cardiomyocytes [97]
Cerox1MouseNuclearInhibits miR-488-3p to enhance the expression of multiple ETC complex I subunits and mitochondrial respiration in N2A neuroblastoma cells [98]
circRNAs
mt-circRNAs
circPUM1HumanNuclearBinds to UQCRC2 to modulate the formation of the UQCRC1-UQCRC2 dimer in mitochondrial complex III in KYSE30 and KYSE410 ESCC cells [99]
SCARHumanMitochondrialBinds to ATP5B to shut down mPTP, thus inhibiting mitochondrial ROS output in liver fibroblasts [76]
mcPGK1HumanMitochondrialPromotes mitochondrial import of PGK1 and is involved in metabolic reprogramming from OXPHOS to glycolysis in liver TICs [100]
ND4, NADH ubiquinone oxidoreductase core subunit 4; ND2, NADH ubiquinone oxidoreductase core subunit 2; ROS, reactive oxygen species; COX1, cytochrome c oxidase subunit 1; ATP6, ATP synthase F0 subunit 6; IFM, interfibrillar mitochondria; SSM, subsarcolemmal mitochondria; CYTB, cytochrome b; ND1, NADH ubiquinone oxidoreductase core subunit 1; COX3, cytochrome c oxidase subunit 3; TSCC, tongue squamous cell carcinoma; COX4, cytochrome c oxidase subunit 4; COX10, cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10; ATP5B, ATP synthase F1 subunit β; MPC1, mitochondrial pyruvate carrier 1; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; HCC, hepatocellular carcinoma; SAMMSON, survival-associated mitochondrial melanoma-specific oncogenic non-coding RNA; Kcnq1ot1, potassium voltage-gated channel subfamily Q member 1 overlapping transcript 1; Cerox1, cytoplasmic endogenous regulator of oxidative phosphorylation 1; circPUM1, circular RNA pumilio-1; UQCRC2, ubiquinol cytochrome c reductase core protein 2; UQCRC1, ubiquinol cytochrome c reductase core protein 1; ESCC, esophageal squamous cell carcinoma; SCAR, steatohepatitis-associated circRNA ATP5B regulator; mPTP, mitochondrial permeability transition pore; mcPGK1, mitochondrial circRNA for translocating phosphoglycerate kinase 1; PGK1, phosphoglycerate kinase 1; TICs, tumor-initiating cells.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kobayashi, A.; Takeiwa, T.; Ikeda, K.; Inoue, S. Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation. Int. J. Mol. Sci. 2023, 24, 9414. https://doi.org/10.3390/ijms24119414

AMA Style

Kobayashi A, Takeiwa T, Ikeda K, Inoue S. Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation. International Journal of Molecular Sciences. 2023; 24(11):9414. https://doi.org/10.3390/ijms24119414

Chicago/Turabian Style

Kobayashi, Ami, Toshihiko Takeiwa, Kazuhiro Ikeda, and Satoshi Inoue. 2023. "Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation" International Journal of Molecular Sciences 24, no. 11: 9414. https://doi.org/10.3390/ijms24119414

APA Style

Kobayashi, A., Takeiwa, T., Ikeda, K., & Inoue, S. (2023). Roles of Noncoding RNAs in Regulation of Mitochondrial Electron Transport Chain and Oxidative Phosphorylation. International Journal of Molecular Sciences, 24(11), 9414. https://doi.org/10.3390/ijms24119414

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop